Population-Based Study on Cancer Incidence in Pharmacist: A Cohort Study in Taiwan

Ya-Wen Lin, Che-Huei Lin, Lee-Wen Pai, Chih-Hsin Mou, Jong-Yi Wang and Ming-Hung Lin
Additional contact information
Ya-Wen Lin: School of Nursing, China Medical University, Taichung 406040, Taiwan
Che-Huei Lin: Department of College Business Administration, National Chiayi University, Chiayi 600355, Taiwan
Lee-Wen Pai: Department of Nursing, Central Taiwan University of Science and Technology, Taichung 406053, Taiwan
Chih-Hsin Mou: Management Office for Health Data, China Medical University Hospital, Taichung 40447, Taiwan
Jong-Yi Wang: Department of Health Services Administration, China Medical University, Taichung 406040, Taiwan
Ming-Hung Lin: College of Pharmacy and Science, Chia Nan University of Pharmacy & Science, Tainan 71710, Taiwan

IJERPH, 2021, vol. 18, issue 23, 1-12

Abstract: Cancer is increasing in rate globally and is leading cause of death among no communicable chronic diseases (NCDs) after cardiovascular disease (CVD). Most of the research focuses on the risk of occupational injury, job stress, mental illness, substance abuse and workplace safety in physicians and nurses. However, fewer studies have investigated the risk of cancer in pharmacists. We compared the matched general population to investigate the risk of cancer in pharmacists in Taiwan. Data were obtained from the Health and Welfare Data Science Center of the Ministry of Health and Welfare in Taiwan. We established a pharmacist group that included 11,568 pharmacists and selected a 4-fold comparison ( n = 46,272) for the non-clinics comparison group, frequency being matched by age, gender and Charlson Comorbidity Index (CCI) score. The pharmacists had a lower but non-significant risk of all cancer (Adjusted hazard ratio [aHR] = 0.96; 95% confidence interval [CI] = 0.85–1.07) compared with the general population. Female pharmacists had a higher risk of cancer than male pharmacists ([aHR] = 1.23; 95% CI = 1.06–1.43). Pharmacists had higher risks of breast cancer in females (aHR = 1.68; 95% CI = 1.35–2.08) and of prostate cancer in males (aHR = 2.18; 95% CI = 1.35–2.08) when compared with the general population. Occupational risk factors could play a role, but they were not evaluated. These epidemiological findings require additional studies to clarify cancer risk mechanisms in pharmacists.

Keywords: pharmacists; occupational; cancer; risk factor (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/23/12625/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/23/12625/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:23:p:12625-:d:691664

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().